China should not prioritise low prices in drug procurement plan, European lobby group says
SHANGHAI, March 14 (Reuters) - A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's centralised drug procurement programme.
The European Union Chamber of Commerce in China also questioned China's recent investigation into quality concerns of off-patent medicines approved for the programme, calling it "unscientific," and lacking in transparency.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
China's National Healthcare Security Administration (NHSA) launched an investigation in January after local media cited doctors in Beijing and Shanghai saying the cheaper generic drugs used at public hospitals did not appear to have the same efficacy or side effects as those made by Western pharmaceutical companies.
The regulator said it had looked into those claims by speaking to relevant experts as well as the heads of seven hospitals and concluded last month that the quality concerns were unsubstantiated.
The European chamber, whose online member directory lists drugmakers and hospitals operating in China, said the probe lacked transparency, because an "in-depth explanation" of its process, and data from it, had not been made public.
"The investigation was deemed unscientific due to a lack of transparency," it said in a statement to Reuters.
Jens Eskelund, the chamber's president, said in a separate statement that it "hopes to see steps taken to ensure that the procurement system for drugs does not prioritise low prices at the expense of product safety and clinical outcomes."
The NHSA did not respond to a Reuters request for comment on the chamber's concerns about the investigation.
An official report issued earlier this month said China would "refine the policy for centralized medicine procurement and enhance quality evaluations and oversight" to ensure consumers' confidence in the medication they use.
China rolled out the bulk-buy programme in 2018 in an attempt to negotiate lower prices from drug manufacturers and has since expanded it to many parts of the country.
The drugs on the list include off-patent blockbusters made by Western pharmaceutical giants as well as generics produced by local players.
While the scheme puts pressure on margins, many drugmakers participate in the tenders to supply public hospitals in large volumes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Courier
2 hours ago
- The Courier
Glenrothes dad's paternity leave campaign after son's traumatic birth
A Glenrothes dad is campaigning for better UK paternity leave following the premature birth of his son. Ryan Connolly and wife Claire welcomed baby Lewis in April last year. He was almost four weeks early and there were complications which saw Claire need emergency surgery. She remained in hospital for several days. Yet, despite the seriousness of the situation, Ryan was only entitled to two weeks leave from his job as an IT project co-ordinator. The 30-year-old said: 'In one of the most important and vulnerable moments of our lives, I don't think it's too much to ask that families are given the time and support to actually be a family.' According to MPs, the UK's paternity leave system is among the worst in the developed world. However, Ryan is supporting the Dad Shift campaign, which aims to change that. He has now spoken of Lewis's traumatic birth, and the days following, as part of that campaign. Ryan said: 'Lewis arrived unexpectedly early—at 36 weeks and 3 days. 'He was born a petite, albeit healthy, 5lb 10oz with a big cry and passed all his checks. 'But Claire's placenta didn't detach as it should have. 'After several failed attempts to remove it, she had to undergo emergency surgery. 'I was left, quite literally, holding the baby while she was taken to theatre. 'Although the operation went well, Claire suffered significant blood loss and needed a transfusion. 'She later had to have a second procedure before the bleeding was finally brought under control.' The new dad added: 'I'll never forget sitting there holding our day-old son, watching monitors as his mum's blood pressure dropped and her skin turned grey from blood loss.' Claire, 31, spent three full days in hospital with Ryan and Lewis at her side. Meanwhile, at night Ryan would go home and try to ready the house for their new baby. 'The whole time, I was painfully aware I was already on day three of my two-week paternity leave,' the Glenrothes dad said. 'We hadn't even made it home yet to adjust, to heal, to simply be together – and I can't help but think how many other dads are in the same position?' Eight European countries, including France, Spain, Belgium and the Netherlands, offer a minimum of four weeks paternity leave. And Glenrothes and Mid Fife MP Richard Baker has joined forces with Ryan and other local dads to push for improvement. The Labour MP said: 'Dads shouldn't have to choose between being present for their newborn and keeping their household afloat. 'Even taking those two weeks off comes at a financial cost.' According to a recent survey by Dad Shift, 70% of 1,911 respondents said they did not feel psychologically ready to return to work when they did. An additional survey saw 86% of 1,565 respondents say current paternity leave limitations also negatively affected their partner's health and wellbeing. The UK Government says it is carrying out a review to see how it can best support working families.
Daily Mirror
a day ago
- Daily Mirror
NHS chief gives verdict on funding settlement outlined in spending review
New NHS England boss Sir Jim Mackey insists the NHS has done "really well" in the spending review - despite a lower rate of increase than under the Tories in 2023 The new boss of the NHS has said the health service has done 'really well' out of the spending review - despite getting a worse funding settlement than under the Tories. Sir Jim Mackey gave his first major speech at the annual NHS Confed Expo conference in Manchester moments before Chancellor Rachel Reeves confirmed the health service will get a major funding squeeze. The Chancellor's spending review will mean a 3% annual budget rise, which is lower than the average 3.6% increases the NHS has received since its founding. It is also lower than the 3.3% rise seen in 2023 under the previous Conservative governments. But Sir Jim told health leaders: "The NHS has done really well relative to other parts of the public service but we all know it's never enough because of the scale of advancement, all the ambition, all things we want to do, the day-to-day cost pressures we're trying to get on top of, etc. "We're always going to be in a world where we want more money, but I think everyone's starting to accept and understand that we've got what the country can afford to give us. We really need to get better value for that money - it is broadly the equivalent of the GDP of Portugal, so it's a huge amount of money by any standards. "It's a huge amount - (the) Government has done us a really good turn compared to other parts of the public service. But it's not going to allow us all to just take our feet off the pedal and just run loose and do what we want to do in this next period, we have still got an awful lot of difficult things to do." Sir Jim succeeded previous chief executive Amanda Pritchard as the Government took direct control of NHS England, which had previously been operationally independent. Chancellor Rachel Reeves delivered her Spending Review, setting out budgets for government departments. She said she has made "tough decisions" but is rejecting "austerity". Healthcare spending generally increases to keep pace with a growing and aging population. The UK spends less on healthcare than most other European countries. The 3% rise will add up to about £30 billion a year extra by the end of the parliament. It comes as the NHS is likely to have to find the cash for above-inflation pay rises for staff and a large chunk of a £1 billion-a-year rise in drug prices ministers have promised to the pharmaceutical industry. Sir Jim acknowledged it will be a struggle for the NHS to improve 'delayed discharges' where hospitals are full of frail but otherwise well people because there is no social care places for them. He added: "Social care in local authorities won't do brilliantly in the spending review… so we will be left with what we can do as much as we can within our gift." It comes as internal Government modelling suggests that without more NHS funding Sir Keir Starmer 's government will miss a key pledge to treat 92% of patients requiring routine care within 18 weeks. The NHS constitutional standard has not been met for a decade. Sally Gainsbury, of the Nuffield Trust think tank, told the Times that "an extra 2.8 per cent in real terms will not fully cover the new demands the health service can expect each year, let alone eliminate previous problems like the waiting list backlog".
Reuters
a day ago
- Reuters
Colombian senator Uribe shows signs of neurological improvement after shooting
BOGOTA, June 11 (Reuters) - Colombian Senator Miguel Uribe remains in a critical condition after being shot in Bogota on Saturday, but has shown signs of neurological improvement, the hospital treating him said in a statement on Wednesday. The 39-year-old, a potential presidential contender, is a member of the opposition right-wing Democratic Center party. He was shot in the head as he was addressing a campaign event in a public park in the capital. "Despite the severity of his condition, there are signs of neurological improvement due to a decrease in cerebral edema. There is also evidence of a trend toward hemodynamic stabilization," the Santa Fe Foundation hospital said.
